Total Credits: .75 including .75 AOA Category 1-A Credit(s)
Obesity is a chronic disease that affects millions of American and costs the US an estimated $173 billion dollars a year. While lifestyle interventions are key to managing obesity, they have limited efficacy. This session will address the current pharmaceutical interventions that have been developed and approved for long-term management of the condition. Many physicians feel uncomfortable prescribing medication for the management of the disease and there is also stigma related to the management of obesity. Given the scope of the obesity problem around the world, physicians need evidence-based treatment options to address this disease.
At the conclusion of this session, the participant should be able to:
- Feel comfortable using anti-obesity medication for the management of overweight and obese patients.
Disclosure Statement: Dr. Flanagan, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.
Accreditation Statement: The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this activity for a maximum of 0.75 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
Grievance Statement: If you are not satisfied with the program, you may file a written grievance by emailing cme@poma.org. Your complaint will be forwarded to the Education Committee for review. The committee will determine if the participant should be reimbursed with no credits or deny the complaint and take the issue into consideration for future programs.
| FlanaganSamanthaHandout (871.3 KB) | Available after Purchase | ||
Samantha P. Flanagan, DO, “Obesity Management and Weight Loss Medications,” is an obesity medicine provider at Women’s Primary Care & Obesity Medicine in King of Prussia, Pennsylvania and part-time faculty at the Philadelphia College of Osteopathic Medicine (PCOM). Board certified in family and obesity medicine, Dr. Flanagan is a graduate of Boston College and a 2017 graduate of PCOM. She completed a family medicine residency at Abington (Pa.) Jefferson Health. Dr. Flanagan is a member of POMA, the American Osteopathic Association, the American Academy of Family Physicians and the Obesity Medicine Association.
She has no relevant financial relationship(s) with ineligible companies to disclose.
|
Current Screening for High School and College Athletes, Including Sudden Death in Sports
Original Program Date: 05/03/2023 |
|
Update in the Management of Congestive Heart Failure with Reduced Ejection Fraction in 2023
Original Program Date: 05/03/2023 |
|
Current Medical, Endovascular and Surgical Management of Carotid Artery Disease
Original Program Date: 05/03/2023 |
|
An Interdisciplinary Approach to Metabolic Disease Management with Cultural Considerations
Original Program Date: 05/04/2023 |